期刊文献+

痛风748例临床特征分析 被引量:15

Clinical characteristics of arthrolithiasis: analysis of 748 cases
原文传递
导出
摘要 痛风病(GOUT)为嘌呤代谢紊乱,尿酸排泄障碍、血尿酸增高所致疾病。临床上表现为高尿酸血症性晶体性关节炎,主要表现为高尿酸血症、急慢性关节炎、痛风石形成,可并发尿酸盐肾病等。随着经济发展和人们生活方式、饮食结构的变化,近年来高尿酸血症和痛风患病率逐年增长,并日渐年轻化。为了更好地认识辽宁地区痛风发病的特点及探讨相关临床治疗,分析辽宁地区痛风的流行和变化趋势,寻找有效的预防、干预及治疗措施。
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2014年第11期1114-1115,共2页 Chinese Journal of Practical Internal Medicine
基金 辽宁省科学计划项目(2011225015)
关键词 痛风 高尿酸血症 关节炎 痛风石 gout hyperuricemia arthritis uratoma
  • 相关文献

参考文献10

  • 1Zampogna G, Andracco R, Parodi M, et al. Has the clinical spectrum of gout changed over the last decades? [J]. Clin Exp Rheumatol, 2012,30 ( 3 ) :414 - 416.
  • 2王一军,李春亚.原发性痛风36例分析[J].郑州大学学报(医学版),2002,37(6):863-863. 被引量:1
  • 3Yamanaka H. Gout and hyperuricemia in young people [ J ]. Curr Opin Rheumato1,2011,23 ( 2 ) : 156 - 160.
  • 4刘桂芝.高尿酸血症患者心电图J波发生情况调查[J].郑州大学学报(医学版),2011,46(4):647-648. 被引量:2
  • 5杨俊,唐海滨,胡艳文,贾豫黔.血尿酸水平与老年高血压患者颈动脉硬化关系探讨[J].贵阳医学院学报,2008,33(2):159-161. 被引量:10
  • 6Bolzetta F, Veronese N, Manzato E, et al. Tophaceous gout in the elderly : a chnical case review [ J ]. Chn Rheumatol, 2012,31 ( 7 ) : 1127 - 1132.
  • 7Chaichian Y, Chohan S, Long-Term Management of Gout : Nonphar- macologic and Pharmacologic Therapies [ J ]. Rheum Dis Clin North Am,2014,40 (2) :357 - 374.
  • 8Roddy E, Choi HK. Epidemiology of Gout [ J ]. Rheum Dis Clin North Am,2014,40(2) :155 - 175.
  • 9Banse C, Fardellone P, Paccou J. Prevalence of treatment of hyperu- ricemic in patients admitted to the Rheumatolugy ward and evalua- tion of compliance with the 2012 ACR Guidelines[ J]. Joint Bone Spine,2014, pii : S1297 - 319X ( 14 ) 00056 - 6.
  • 10Grassi D, Pontremoli R, Bocale R, et al. Therapeutic Approaches to Chronic Hyperuricemia and Gout [ J ]. High Blood Press Cardiovasc Prev,2014[ Pub Ahead of Print].

二级参考文献16

共引文献10

同被引文献109

  • 1姚宗良,姜胜杰,刘慧,万希琴,丁志高.青岛市沿海社区人群高尿酸血症与痛风的流行病学调查[J].中华风湿病学杂志,2007,11(11):672-675. 被引量:24
  • 2Khanna D, Khanna PP, Fitzgerald JD, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis[J]. Arthritis Care mes (Hoboken), 2012, 64(10): 1447- 1461.
  • 3Zhang W~ Doherty M, Pascual E, et al. EULAR evidence based recommendation for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCLSU)[J]. Ann Rheum Dis, 2006, 65(10): 1301-1311.
  • 4Dalbeth N, Lauterio TJ, Wolfe HR. Mechanism of action of colchicine in the treatment of gout[J]. Clin Ther, 2014, 36(10): 1465-1479.
  • 5Van Durme CM, Wechalekar MD, Buchhinder R, et al. Non- steroidal anti-inflammatory drugs for acute gout[J]. Cochrane Database Syst Rev, 2014, 9: CD010120.
  • 6Khanna PP, Gladue HS, Singh MK, et al. Treatment of acute gout: a systematic review[J]. Semin Arthritis Rheum, 2014, 44(1): 31-38.
  • 7Janssens HJ, Janssen M, van de Lisdonk EH, et al. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial[J]. Lancet, 2008, 371(9627): 1854-1860.
  • 8Van Echteld I, Wechalekar MD, Schlesinger N, et al. Colchicine for acute gout[J]. Cochrane Database Syst Rev, 2014, 8: CD006190.
  • 9DOHERTY M,JANSEN T L,NUKI G, et al. Gout: why is thiscurable disease so seldom cured. [J]. Ann Rheum Dis, 2012,71(11) : 1765 - 1770.
  • 10KHANNA D, FITZGERALD J D,KHANNA P P, et al. 2012American College of Rheumatology guidelines for management ofgout. Part 1 : systematic nonpharmacologic and pharmacologic thera-peutic approaches to hyperuricemia [ J ]. Arthritis Care Res(Hoboken),2012,64(10) : 1431 -1446.

引证文献15

二级引证文献175

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部